Group One Trading
BRLI

Group One Trading’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Group One Trading’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,400
Closed -$182K – 5625
2015
Q2 		$182K Sell
4,400
-5,900
-57% -$212K ﹤0.01% 2593
2015
Q1 		$363K Buy
10,300
+2,800
+37% +$94.7K 0.01% 1875
2014
Q4 		$241K Sell
7,500
-4,600
-38% -$133K ﹤0.01% 2154
2014
Q3 		$340K Buy
12,100
+8,600
+246% +$262K 0.01% 1922
2014
Q2 		$106K Sell
3,500
-79,600
-96% -$2.2M ﹤0.01% 2938
2014
Q1 		$2.3M Sell
83,100
-5,000
-6% -$131K 0.04% 558
2013
Q4 		$2.25M Buy
88,100
+63,400
+257% +$1.95M 0.03% 591
2013
Q3 		$738K Sell
24,700
-38,100
-61% -$1.06M 0.01% 1257
2013
Q2 		$1.81M Buy
+62,800
New +$1.73M 0.04% 475

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Group One Trading's BRLI Position: Q1 2015 in Review

Group One Trading sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q1 2015, closing a stake of 1,959 shares — an estimated $66.3K sold.

Group One Trading first reported a position in BRLI in Q4 2013 and held it in 4 quarters. The position peaked at $903K in Q4 2013. 168 funds tracked by Wall St. Rank hold BRLI as of Q1 2015.

  • Group One Trading reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q1 2015 after selling out during the quarter.
  • Group One Trading sold 1,959 BIO-REFERENCE LABS INC-NEW- shares in Q1 2015, an estimated $66.3K.
  • Group One Trading first reported a position in BIO-REFERENCE LABS INC-NEW- in Q4 2013 and held it in 4 quarters.
  • Group One Trading's BIO-REFERENCE LABS INC-NEW- position peaked at $903K in Q4 2013.
  • 168 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q1 2015.

Based on Group One Trading's 13F filing for Q1 2015, filed 14 May 2015.